Journal of Cancer Research and Pharmacology

Journal of Cancer Research and Pharmacology

Evaluation of the Antioxidant Properties of Apigenin on Radiation-Induced Oxidative Damage in the Rat Brain

Document Type : Original Article

Authors
1 Physiology Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
2 Department of Biology, Faculty of Basic Sciences, University of Guilan, Rasht, Iran
3 Department of Radiology and Nuclear Medicine, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran
4 Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
5 Department of Medical Physics and Radiology, School of Allied Medical Sciences, Kashan University of Medical Sciences, Kashan, Iran
6 Department of Radiology, School of Paramedical Sciences, Guilan University of Medical Sciences, Rasht, Iran
Abstract
Background and Aims: Apigenin (APG) has displayed antioxidant, anti-inflammatory and tissue regeneration characteristics. The current research assessed the radioprotective influence of APG (50 mg/kg) on the brain tissues of rats following irradiation (IR).
Methods: This experimental study utilized 20 adult male Wistar rats with a weight range of 180–200 g. The animals were categorized in four identical groups, consisting of control, IR alone, APG alone, and APG + IR. These animals were subjected to a single 15 Gy dose using a linear accelerator unit at a dose rate of 200 cGy/min. The levels of various oxidative stress indicators, including malondialdehyde (MDA), nitric oxide (NO), glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD), were scrutinized in various groups. To measure the extent of oxidative stress ensuing from the IR, the quantities of the five markers (MDA, NO, GPx, CAT, and SOD) were measured using spectrophotometric techniques and commercially available kits.
Results: Ionizing radiation significantly increased the levels of MDA and NO while significantly decreasing the activities of GPx, CAT, and SOD in rat brain tissues. In contrast, pretreatment with APG resulted in a non-significant reduction in MDA and NO levels, a significant increase in GPx activity, and non-significant increases in both CAT and SOD activities in the brains of IR-exposed animals.
Conclusion: These findings suggest that APG has the ability to boost the antioxidant protection of rat brain tissue and could alleviate the detrimental consequences of being exposed to radiation in the brain tissues. However, the use of APG as a new radioprotector agent in patients with brain tumors needs further research.
Keywords

  1. Girardi F, Allemani C, Coleman MP. Worldwide trends in survival from common childhood brain tumors: a systematic review. J Glob Oncol. 2019;5:1-25. doi:10.1200/JGO.19.00140 PMid:31682549 PMCid:PMC6882508
  2. Pollack IF, Agnihotri S, Broniscer A. Childhood brain tumors: current management, biological insights, and future directions: JNSPG 75th Anniversary Invited Review Article. J Neurosurg Pediatr. 2019;23(3):261-73. doi:10.3171/2018.10.PEDS18377 PMid:30835699 PMCid:PMC6823600
  3. Tohidinezhad F, Di Perri D, Zegers CM, Dijkstra J, Anten M, Dekker A, et al. Prediction models for radiation-induced neurocognitive decline in adult patients with primary or secondary brain tumors: A systematic review. Front Psychol. 2022; 13:853472. doi:10.3389/fpsyg.2022.853472 PMid:35432113 PMCid:PMC9009149
  4. Roda E, Bottone MG. Brain cancers: new perspectives and therapies. Front Neurosci. 2022;16:857408. doi:10.3389/fnins.2022.857408 PMid:35237126 PMCid:PMC8883042
  5. Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. 2017;13(1):52-64. doi:10.1038/nrneurol.2016.185 PMid:27982041 PMCid:PMC5805381
  6. Kepka L, Tyc-Szczepaniak D, Osowiecka K, Sprawka A, Trąbska-Kluch B, Czeremszynska B. Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial. Clin Transl Oncol. 2018;20:150-9. doi:10.1007/s12094-017-1703-5 PMid:28616720
  7. Shahjalal M, Sultana M, Gow J, Hoque ME, Mistry SK, Hossain A, et al. Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: a cancer-specific exploration. BMC Cancer. 2023;23(1):1208. doi:10.1186/s12885-023-11670-z PMid:38062438 PMCid:PMC10704718
  8. Nicol C, Pinkham MB, Lion K, Foote M, McBean A, Higgins M, et al. Individuals' perceptions of health and well-being in the context of stereotactic radiosurgery for benign brain tumour: A longitudinal qualitative investigation. Neuropsychol Rehabil. 2024;34(2):244-67. doi:10.1080/09602011.2023.2181190 PMid:36927243
  9. Wirsching H-G, Tabatabai G, Roelcke U, Hottinger A, Jörger F, Schmid A, et al. Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Ann Oncol. 2018;29(6):1423-30. doi:10.1093/annonc/mdy120 PMid:29648580
  10. Weichselbaum RR, Liang H, Deng L, Fu Y-X. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017; 14(6):365-79. doi:10.1038/nrclinonc.2016.211 PMid:28094262
  11. Mohan G, TP AH, AJ J, KM SD, Narayanasamy A, Vellingiri B. Recent advances in radiotherapy and its associated side effects in cancer-a review. J Basic Appl Zool. 2019;80(1):1-10. doi:10.1186/s41936-019-0083-5
  12. Barazzuol L, Coppes RP, van Luijk P. Prevention and treatment of radiotherapy‐induced side effects. Mol Oncol. 2020;14(7): 1538-54. doi:10.1002/1878-0261.12750 PMid:32521079 PMCid:PMC7332214
  13. Zhang Q-Y, Wang F-X, Jia K-K, Kong L-D. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 2018;9:1253. doi:10.3389/fphar.2018.01253 PMid:30459615 PMCid:PMC6232953
  14. Liu Y-Q, Wang X-L, He D-H, Cheng Y-X. Protection against chemotherapy-and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine. 2021;80:153402. doi:10.1016/j.phymed.2020.153402 PMid:33203590
  15. Zhang Y, Huang Y, Li Z, Wu H, Zou B, Xu Y. Exploring natural products as radioprotective agents for cancer therapy: Mechanisms, challenges, and opportunities. Cancers (Basel). 2023;15(14):3585. doi:10.3390/cancers15143585 PMid:37509245
  16. Xavier JR, Chauhan OP, Sharma RK. Natural plant products as promising radio protectors. Bull Env Pharmacol Life Sci, Spl. 2022(4):261-76.
  17. Stasiłowicz-Krzemień A, Gościniak A, Formanowicz D, Cielecka-Piontek J. Natural guardians: Natural compounds as radioprotectors in cancer therapy. Int J Mol Sci. 2024;25(13):6937. doi:10.3390/ijms25136937 PMid:39000045 PMCid:PMC11241526
  18. Seyedpour N, Motevaseli E, Taeb S, Nowrouzi A, Mirzaei F, Bahri M, et al. Protective effects of alpha-lipoic acid, resveratrol, and apigenin against oxidative damages, histopathological changes, and mortality induced by lung irradiation in rats. Curr Radiopharm. 2024;17(1):99-110. doi:10.2174/0118744710244357231018070313 PMid:37909433
  19. Institute of Laboratory Animal Resources (US). Committee on Care, Use of Laboratory Animals. Guide for the care and use of laboratory animals. Bethesda (MD): US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1986. NIH Publication No.: 85-23.
  20. Ghobadi A, Shirazi A, Najafi M, Kahkesh MH, Rezapoor S. Melatonin Ameliorates Radiation-Induced Oxidative Stress at Targeted and Nontargeted Lung Tissue. J Med Phys. 2017; 42 (4): 241-4. doi:10.4103/jmp.JMP_60_17 PMid:29296038 PMCid:PMC5744452
  21. Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol. 2008;440:361-80. doi:10.1016/S0076-6879(07)00823-3 PMid:18423230
  22. Shabeeb D, Musa AE, Abd Ali HS, Najafi M. Curcumin Protects Against Radiotherapy-Induced Oxidative Injury to the Skin. Drug Des Devel Ther. 2020;14:3159-63. doi:10.2147/DDDT.S265228 PMid:32848362 PMCid:PMC7429408
  23. Fischer N, Seo E-J, Efferth T. Prevention from radiation damage by natural products. Phytomedicine. 2018;47:192-200. doi:10.1016/j.phymed.2017.11.005 PMid:30166104
  24. Najafi M, Shirazi A, Motevaseli E, Rezaeyan A, Salajegheh A, Rezapoor S. Melatonin as an anti-inflammatory agent in radiotherapy. Inflammopharmacology. 2017;25:403-13. doi:10.1007/s10787-017-0332-5 PMid:28255737
  25. Raj S, Manchanda R, Bhandari M, Alam MS. Review on natural bioactive products as radioprotective therapeutics: Present and past perspective. Curr Pharm Biotechnol. 2022;23(14):1721-38. doi:10.2174/1389201023666220110104645 PMid:35016594
  26. Akbari B, Baghaei‐Yazdi N, Bahmaie M, Mahdavi Abhari F. The role of plant‐derived natural antioxidants in reduction of oxidative stress. BioFactors. 2022;48(3):611-33. doi:10.1002/biof.1831 PMid:35229925
  27. Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN, et al. Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism (s) of action. Front Pharmacol. 2022;13:283. doi:10.3389/fphar.2022.806470 PMid:35237163 PMCid:PMC8882865
  28. Liu D, Peng R, Chen Z, Yu H, Wang S, Dong S, et al. The Protective Effects of Apigenin Against Radiation‐Induced Intestinal Injury. Dose-Response. 2022;20(3): 15593258221113791. doi:10.1177/15593258221113791 PMid:35859853 PMCid:PMC9289922
  29. Allemailem KS, Almatroudi A, Alharbi HOA, AlSuhaymi N, Alsugoor MH, Aldakheel FM, et al. Apigenin: A bioflavonoid with a promising role in disease prevention and treatment. Biomedicines. 2024;12(6):1353. doi:10.3390/biomedicines12061353 PMid:38927560 PMCid:PMC11202028
  30. Monadi T, Mohajer Z, Soltani A, Khazeei Tabari MA, Manayi A, Azadbakht M. The influence of apigenin on cellular responses to radiation: From protection to sensitization. Biofactors. 2025;51(1):e2113. doi:10.1002/biof.2113 PMid:39134426
  31. Begum N, Rajendra Prasad N, Kanimozhi G, Agilan B. Apigenin prevents gamma radiation-induced gastrointestinal damages by modulating inflammatory and apoptotic signalling mediators. Nat Prod Res. 2022;36(6):1631-5. doi:10.1080/14786419.2021.1893316 PMid:33673794
  32. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology. 2003; 189 (1-2):1-20. doi:10.1016/S0300-483X(03)00149-5 PMid:12821279
  33. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 2010;15(4):360-71. doi:10.1634/theoncologist.2009-S104 PMid:20413641 PMCid:PMC3076305
  34. Jagetia GC. Radioprotective potential of plants and herbs against the effects of ionizing radiation. J Clin Biochem Nutr. 2007; 40 (2):74-81. doi:10.3164/jcbn.40.74 PMid:18188408 PMCid:PMC2127223
  35. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006;97(6):1634-58. doi:10.1111/j.1471-4159.2006.03907.x Mid:16805774
  36. Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011;82(4):513-23. doi:10.1016/j.fitote.2011.01.018 PMid:21277359
  37. Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochim Biophys Acta. 2013;1830(5):3289-303. doi:10.1016/j.bbagen.2012.11.020 PMid:23201771
  38. Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401-26. doi:10.1146/annurev-pharmtox-011112-140320 PMid:23294312 PMCid:PMC4680839
  39. Patel D, Shukla S, Gupta S. Apigenin and cancer chemoprevention: progress, potential and promise (review). Int J Oncol. 2007;30(1):233-45. doi:10.3892/ijo.30.1.233 PMid:17143534
  40. Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD. Radiation-induced brain injury: A review. Front Oncol. 2012;2:73. doi:10.3389/fonc.2012.00073 PMid:22833841 PMCid:PMC3400082
Volume 1, Issue 1
Summer 2025
Pages 3-11

  • Receive Date 10 August 2025
  • Revise Date 04 September 2025
  • Accept Date 13 September 2025